- Home
- MRNA vs COKE Comparison
MRNA vs COKE Comparison
Compare MRNA & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNA
- COKE
- Stock Information
- Founded
- MRNA 2010
- COKE 1902
- Country
- MRNA United States
- COKE United States
- Employees
- MRNA N/A
- COKE N/A
- Industry
- MRNA Biotechnology: Biological Products (No Diagnostic Substances)
- COKE Beverages (Production/Distribution)
- Sector
- MRNA Health Care
- COKE Consumer Staples
- Exchange
- MRNA Nasdaq
- COKE Nasdaq
- Market Cap
- MRNA 10.9B
- COKE 10.2B
- IPO Year
- MRNA 2018
- COKE N/A
- Fundamental
- Price
- MRNA $24.47
- COKE $122.60
- Analyst Decision
- MRNA Hold
- COKE
- Analyst Count
- MRNA 19
- COKE 0
- Target Price
- MRNA $43.50
- COKE N/A
- AVG Volume (30 Days)
- MRNA 9.9M
- COKE 408.2K
- Earning Date
- MRNA 11-06-2025
- COKE 10-29-2025
- Dividend Yield
- MRNA N/A
- COKE 0.82%
- EPS Growth
- MRNA N/A
- COKE 24.05
- EPS
- MRNA N/A
- COKE 6.71
- Revenue
- MRNA $3,078,000,000.00
- COKE $6,947,643,000.00
- Revenue This Year
- MRNA N/A
- COKE N/A
- Revenue Next Year
- MRNA $10.17
- COKE N/A
- P/E Ratio
- MRNA N/A
- COKE $18.27
- Revenue Growth
- MRNA N/A
- COKE 3.22
- 52 Week Low
- MRNA $23.15
- COKE $105.21
- 52 Week High
- MRNA $79.96
- COKE $146.09
- Technical
- Relative Strength Index (RSI)
- MRNA 38.50
- COKE 66.07
- Support Level
- MRNA $23.78
- COKE $119.00
- Resistance Level
- MRNA $25.48
- COKE $117.80
- Average True Range (ATR)
- MRNA 1.09
- COKE 2.22
- MACD
- MRNA 0.05
- COKE 0.53
- Stochastic Oscillator
- MRNA 25.00
- COKE 87.99
About MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets and manufactures nonalcoholic beverages. It offer a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages and the Company's principal sparkling beverage is Coca Cola. Still beverages include energy products and noncarbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices and sports drinks. The Company has three operating segments: Nonalcoholic Beverages, All Other and Eliminations. key revenue is generated from Nonalcoholic Beverages.